Canadian Center for Vaccinology (CCfV)

Canadian Center for Vaccinology (CCfV) is a research institute based in Canada with a vision to develop, implement, and evaluate vaccinology technologies and vaccines for infectious diseases for a healthier future. Established in 2007 and located in the IWK Health Centre in Halifax, CCfV is a collaborative effort involving Dalhousie University, the IWK Health Centre, and the Nova Scotia Health Authority. The organization's mission focuses on addressing infectious diseases impacting Canadian and global health and aims to train experts in this critical and evolving field. The most recent investment in CCfV was a $1.00M grant investment by GlaxoSmithKline on 31 May 2023. This injection of funds is poised to support the continuation of CCfV's essential work in developing and evaluating vaccine technologies and their applications in combatting infectious diseases. The collaboration with a major pharmaceutical player like GlaxoSmithKline also underscores the industry's confidence in CCfV's initiatives. With its focus on impactful vaccine development and strategic partnerships, CCfV is poised to further cement its position as a pivotal player in the field of vaccinology.